Universitat Politècnica de Catalunya-ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2023

  1. Cold plasma and inhibition of STAT3 selectively target tumorigenicity in osteosarcoma

    Redox Biology, Vol. 62

  2. Cold plasma-treated medium preferentially eliminates doxorubicin-resistant osteosarcoma cells

    Free Radical Biology and Medicine, Vol. 209, pp. 127-134

2022

  1. Cold atmospheric plasma enhances doxorubicin selectivity in metastasic bone cancer

    Free Radical Biology and Medicine, Vol. 189, pp. 32-41

2021

  1. Cold atmospheric plasma: A new strategy based primarily on oxidative stress for osteosarcoma therapy

    Journal of Clinical Medicine, Vol. 10, Núm. 4, pp. 1-29

  2. Evaluation of the effects of cold atmospheric plasma and plasma-treated liquids in cancer cell cultures

    Nature Protocols, Vol. 16, Núm. 6, pp. 2826-2850

  3. Mithramycin delivery systems to develop effective therapies in sarcomas

    Journal of Nanobiotechnology, Vol. 19, Núm. 1

  4. Osteosarcoma tissue-engineered model challenges oxidative stress therapy revealing promoted cancer stem cell properties

    Free Radical Biology and Medicine, Vol. 164, pp. 107-118

2020

  1. Cold plasma-treated ringer’s saline: A weapon to target osteosarcoma

    Cancers, Vol. 12, Núm. 1

2019

  1. Pyruvate Plays a Main Role in the Antitumoral Selectivity of Cold Atmospheric Plasma in Osteosarcoma

    Scientific Reports, Vol. 9, Núm. 1